Sarah Buckley

Sarah Buckley's work experience begins in 2017 as an Acting Instructor in Hematology/Oncology at Fred Hutch. In 2018, they join CTI BioPharma, where they hold various roles including Associate Medical Director, Medical Director, Senior Medical Director, and Vice President and Head of Clinical Affairs. In 2023, they transition to Sobi - Swedish Orphan Biovitrum AB as the VP, Medicine Development Lead in the Global Medical Affairs & Clinical Science division.

Sarah Buckley's education history includes a Bachelor of Science degree in Biology from the Massachusetts Institute of Technology, which they obtained from 2002 to 2006. Sarah then pursued a Doctor of Medicine degree from New York University from 2007 to 2011. Following this, they completed an Internal Medicine Residency Program at the University of Washington from 2011 to 2014. Finally, they obtained a Hematology/Oncology Fellowship from the University of Washington, which they completed from 2014 to 2017.